CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation

By                    

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 253-261

Spandidos Publications

Access to resources Recommend Favorite

Trichosanthin down-regulated p210^Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562

By Zhang Kunzhong   Xu Jianhua   Huang Xiuwang   Wu Lixian   Wen Caixia   Hu Yingying   Su Yu   Chen Yuanzhong   Zhang Zhiqiang  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 581-587

Springer Publishing Company

Access to resources Recommend Favorite

Multiple copies of BCR-ABL fusion gene on two isodicentric Philadelphia chromosomes in an imatinib mesylateresistant chronic myeloid leukemia patient

By          

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1579-1582

Spandidos Publications

Access to resources Recommend Favorite

Imatinib-based therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia: A case report and literature review

By              

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2051-2054

Spandidos Publications

Access to resources Recommend Favorite

Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion

By Czyz Anna  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1123-1126

Humana Press, Inc

Access to resources Recommend Favorite